Zydus Lifesciences announced the launch of Anyra, India's first indigenously developed biosimilar of Aflibercept 2 mg, aimed at treating a range of serious retinal disorders.

Zydus Lifesciences launches Anyra, India’s first indigenous biosimilar of Aflibercept, aiming to enhance affordable access to advanced diabetic eye-care treatments and strengthen the country’s ...

Learn about central retinal vein occlusion (CRVO), its causes, symptoms, diagnosis, and treatment options for vision loss.

Get a closer look at the biotech ophthalmology landscape to discover exactly how companies are approaching the treatment of eye diseases.

Zydus Lifesciences has launched Anyra, India's first indigenously developed biosimilar for treating visual impairment due to conditions like diabetes.

Opus Genetics, Inc. (Nasdaq: IRD) (“Opus Genetics” or the “Company”), a clinical-stage biopharmaceutical company developing ...

Thyroid hormone and Vitamin A transform blue eye cells into red and green ones. This transition builds the eye’s center, ...

How does our DNA store the massive amount of information needed to build a human being? And what happens when it's stored incorrectly? Jesse Dixon, MD, Ph.D., has spent years studying the way this ...

GenSight Biologics ("GenSight Biologics" or the "Company") (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a ...

Zydus Lifesciences is in focus after receiving USFDA clearance with zero observations for its Ahmedabad facility and ...

Humans develop sharp vision during early fetal development thanks to an interplay between a vitamin A derivative and thyroid hormones in the retina, Johns Hopkins University scientists have found. The ...